EASD 2023: a Deeper Dive Into Type 1 and Type 2 Diabetes

The upcoming European Association for the Study of Diabetes conference will feature fewer blockbuster trials than did the American Diabetes Association’s June meeting, but more in-depth analysis.

Related Keywords

United States ,Copenhagen ,Køavn ,Denmark ,Germany ,Belgium ,Hamburg ,Asteno ,Hovedstaden ,American ,Tina Vilsb ,Eli Lilly ,Chantal Mathieu ,Novo Nordisk Foundation Diabetes Prize For Excellence ,Boehringer Ingelheim ,Sun Pharmaceuticals ,Steno Diabetes Center ,European Association For The Study Of Diabetes ,Amgen ,American Diabetes Association ,University Hospital Gasthuisberg Leuven ,Novo Nordisk ,Astrazeneca ,European Association ,Hyperglycaemic Crisis ,Adult Patients ,Diabetes Care ,Secretary Tina Vilsb ,Medscape Medical ,Disease Modifying ,Many Ways ,Minkowski Prize Lecture ,Lilly Anniversary Prize Lecture ,Both Disease Modifying ,Claude Bernard Lecture ,Albert Renold Lecture ,Novo Nordisk Foundation Diabetes Prize ,Excellence Lecture ,Camillo Golgi Lecture ,From Classical ,Diabetes Mellitus Type 2 ,Iabetes Mellitus Type Ii ,Type 2 Diabetes ,Europe ,European ,Obesity ,Bese ,Diabetes Mellitus Type 1 ,Iabetes Mellitus Type I ,Type 1 Diabetes ,Incretin Hormones ,Incretins ,Remission ,Renal Disease ,Kidney Disease ,Kidney Disorder ,Renal Disorder ,Ephropathy ,Washington Dc District Of Columbia ,Hypoglycemia ,Washington ,Chronic Renal Failure ,Hronic Kidney Fail ,